Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study

por Harris, Stewart B., Ajala, Olubukola, Bari, Basel, Liutkus, Joanne, Hahn, Jina, Martyn, Oliver, Zwicker, Deborah
Publicado 2021

Use of once‐weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study

por Yale, Jean‐François, Catarig, Andrei‐Mircea, Grau, Katrine, Harris, Stewart, Klimek‐Abercrombie, Agnieszka, Rabasa‐Lhoret, Rémi, Reardon, Laura, Woo, Vincent, Liutkus, Joanne
Publicado 2021

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups

por Yale, Jean-François, Bodholdt, Ulrik, Catarig, Andrei-Mircea, Catrina, Sergiu, Clark, Alice, Ekberg, Neda Rajamand, Erhan, Umut, Holmes, Patrick, Knudsen, Søren Tang, Liutkus, Joanne, Sathyapalan, Thozhukat, Schultes, Bernd, Rudofsky, Gottfried
Publicado 2022